Pharmaceutical industry

The state of prescription drug spending

Data: Centers for Medicare & Medicaid Services' Office of the Actuary; Chart: Axios Visuals

Spending on prescription drugs in 2018 — both through premiums and out-of-pocket costs — grew a moderate 2.5% from the previous year, which was below the growth rates for hospital and doctor services.

Yes, but: That doesn't give a true accounting of total pharmaceutical spending. Spending on common and expensive drugs that are administered by providers is buried within the hospital and doctor statistics.

The strange bedfellows opposing drug-pricing bills across the U.S.

A group opposing drug pricing measures around the country includes major pharmaceutical companies as well as large construction-industry unions, the New York Times reports — strange bedfellows, to say the least.

Why it matters: Ads run by the Pharmaceutical Industry Labor-Management Association may confuse public perception of the nature of opposition to drug-pricing measures.